<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03480789</url>
  </required_header>
  <id_info>
    <org_study_id>sleep in ICU</org_study_id>
    <nct_id>NCT03480789</nct_id>
  </id_info>
  <brief_title>the Influence of Sleep Improvement Through Different Methods on Patients in ICU</brief_title>
  <official_title>the Influence of Sleep Improvement Through Different Methods on Patients in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Medical Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Medical Association</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to
      four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and
      the usual group. The sleep quality would be evaluated by the EEG monitor and the metabolic
      level, the inflammation and nutrition status would be detected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to
      four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and
      the usual group. The sleep quality would be evaluated by the EEG monitor and the metabolic
      level, the inflammation and nutrition status would be detected. The research aims to confirm
      that the sleep quality could have a great influence on patients in the ICU and different
      interventions would make various changes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2018</start_date>
  <completion_date type="Anticipated">July 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the total time of sleep</measure>
    <time_frame>the first 24hours in the icu</time_frame>
    <description>using EEG records the time of sleep and different sleep phases</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Metabolic Problems</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>eye patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wearing the eye patch from 22:00 to 6:00 of the next day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>given dexmedetomidine to meet RASS -1 from 22:00 to 6:00 of the next day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eye patch + DEX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>given dexmedetomidine to meet RASS -1 and wearing the eye patch from 22:00 to 6:00 of the next day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treatment as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>given dexmedetomidine to meet RASS -1 from 22:00 to 6:00 of the next day</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_label>eye patch + DEX</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>eye patch</intervention_name>
    <description>wearing the eye patch from 22:00 to 6:00 of the next day</description>
    <arm_group_label>eye patch</arm_group_label>
    <arm_group_label>eye patch + DEX</arm_group_label>
    <other_name>blinders</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the postoperative patients that admission to icu is more than 48h

        Exclusion Criteria:

          -  pregnant or breastfeeding

          -  sleep disorders before operation

          -  poor liver or kidney function

          -  post craniocerebral operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wenkui Yu, Ph.D</last_name>
    <phone>02568182222</phone>
    <phone_ext>60506</phone_ext>
    <email>yudrnj@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Affliated Drum Tower Hospital, Medical School of Nanjing University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenkui Yu</last_name>
      <phone>02568182222</phone>
      <phone_ext>60506</phone_ext>
      <email>yudrnj@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2018</study_first_submitted>
  <study_first_submitted_qc>March 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

